review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Aellig WH | |
P2860 | cites work | Clinical pharmacology, physiology and pathophysiology of superficial veins--2 | Q34346189 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
pathophysiology | Q1135939 | ||
P304 | page(s) | 181-196 | |
P577 | publication date | 1994-09-01 | |
P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
P1476 | title | Clinical pharmacology, physiology and pathophysiology of superficial veins--1. | |
P478 | volume | 38 |
Q77360278 | Amiodarone causes endothelium-dependent vasodilation in human hand veins in vivo |
Q35030731 | Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications |
Q33146896 | Autonomic control of the venous system in health and disease: effects of drugs |
Q70904626 | Autonomic dysreflexia in tetraplegic patients: evidence for alpha-adrenoceptor hyper-responsiveness |
Q34777529 | Cardiac changes induced by immersion and breath-hold diving in humans |
Q34334935 | Clinical pharmacology of alpha1A selective and nonselective alpha1-blockers |
Q41987112 | Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man. |
Q28367565 | Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man |
Q71766493 | Cumulative and noncumulative dose-response curves to noradrenaline on the dorsal hand vein |
Q33955008 | Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype. |
Q43724984 | Diameter, pressure and compliance relationships in dorsal hand veins |
Q52306427 | Direct angiotensin converting enzyme inhibitor-mediated venodilation. |
Q35027775 | Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo. |
Q71220601 | Effects of different congestion pressures on the diameter of the dorsal hand vein and on its apparent sensitivity to noradrenaline |
Q73794611 | Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humans |
Q73794607 | Familial studies of heritability of alpha1-adrenergic receptor responsiveness in superficial veins |
Q37067189 | Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans |
Q50522005 | Heparin attenuates norepinephrine-induced venoconstriction. |
Q28385491 | Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo |
Q44412672 | Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome |
Q44856244 | Magnesium-induced vasodilation in the dorsal hand vein |
Q34234030 | Measurement of body venous tone |
Q56832856 | Neuropeptide Y in human hand veins: Pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivo* |
Q44310019 | Prostaglandin modulation of venoconstriction to physiological stress in normals and heart failure patients |
Q73198479 | Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels |
Q44362842 | Reproducibility of dorsal hand vein responses to phenylephrine and prostaglandin F2 alpha using the dorsal hand vein compliance method. |
Q36053315 | The effects of age on human venous responsiveness to neuropeptide Y. |
Q48483109 | Vascular endothelial dysfunction in patients with mild obstructive sleep apnea syndrome |
Q46488675 | Venous endothelial function in heart failure: comparison with healthy controls and effect of clinical compensation |
Q46917883 | Venous or arterial endothelium evaluation for early cardiovascular dysfunction in hypertensive patients? |
Search more.